You are here

Article Text

Article menu
Download PDFPDF
Letters to JMG
Association of genetic variants in the HDL receptor, SR-B1, with abnormal lipids in women with coronary artery disease
  1. J J McCarthy1,
  2. T Lehner2,
  3. C Reeves3,
  4. D J Moliterno4,
  5. L K Newby5,
  6. W J Rogers6,
  7. E J Topol4,
  8. for the Genequest investigators*
  1. 1School of Public Health, San Diego State University, San Diego, CA, USA
  2. 2Rockefeller University, New York, NY, USA
  3. 3Millennium Pharmaceuticals Inc, Cambridge, MA, USA
  4. 4Cleveland Clinic Foundation, Cleveland, OH, USA
  5. 5Duke University Medical Center, Durham, NC, USA
  6. 6University of Alabama Medical Center, Birmingham, AL, USA
  1. Correspondence to:
 Dr J J McCarthy, School of Public Health, San Diego State University, 5500 Campanile Drive, San Diego, CA 92182-4162, USA;
 mccarthy{at}mail.sdsu.edu

https://doi.org/10.1136/jmg.40.6.453

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Plasma lipid concentrations are complex traits having both environmental and genetic determinants. About half of the variation in HDL-C and TG may be genetic1–3 with the same genes possibly accounting for the correlated traits of LDL particle size, TG, and HDL-C.4 A number of variants in candidate genes have been implicated in the regulation of plasma lipid levels.5 In addition, genome scans have identified chromosomal regions with suggestive linkage to the TG:HDL-C ratio and other lipid parameters.6,7 Nonetheless, much of the genetic variability in HDL-C and TG levels remains unexplained.

    Decreased HDL cholesterol (HDL-C) and raised triglyceride (TG) levels are well known risk factors for the development of coronary artery disease (CAD) and atherosclerosis.8 Plasma TG and HDL-C levels are highly correlated, but there is some evidence that they may exert independent effects on coronary disease risk.9 Indeed, the simultaneous use of both may more accurately predict risk of coronary disease. Among patients with low HDL-C, risk of CAD was more than doubled in those with concurrent high TG compared to those with low TG levels in both the PROCAM10 and Helsinki Heart studies.11 Furthermore, the ratio of TG:HDL-C has been shown to correlate with LDL particle size12 and is a powerful predictor of future myocardial infarction.13

    The scavenger receptor class B type 1, SR-B1, is a key component in the reverse cholesterol transport pathway where it binds HDL-C with high affinity and is involved in the selective transfer of lipids from HDL-C.14,15 It is expressed primarily in liver and non-placental steroidogenic tissues and mediates selective cholesterol uptake by a mechanism distinct from the classical low density lipoprotein cholesterol (LDL-C) receptor pathway.16 Previous studies17,18 have found single nucleotide polymorphisms (SNPs) in the gene …

    View Full Text

    Footnotes

    • ↵* Listed in the Appendix